124 related articles for article (PubMed ID: 9199074)
1. [Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].
Rader CP; Kramer C; König A; Gohlke F; Eulert J
Z Orthop Ihre Grenzgeb; 1997; 135(1):52-7. PubMed ID: 9199074
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty.
Rader CP; Kramer C; König A; Hendrich C; Eulert J
J Arthroplasty; 1998 Feb; 13(2):180-5. PubMed ID: 9526211
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
Colwell CW; Spiro TE
Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with an ankle joint motion device in prevention of thrombosis in patients after total endoprosthesis knee replacement].
Rader CP; Kramer C; Hendrich C; König A; Gohlke F; Eulert J
Z Orthop Ihre Grenzgeb; 1998; 136(5):467-70. PubMed ID: 9823645
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
[TBL] [Abstract][Full Text] [Related]
6. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
[TBL] [Abstract][Full Text] [Related]
8. Postoperative anticoagulation in vascular surgery: part 1. A retrospective comparison of clinical outcomes for unfractionated heparin versus low-molecular-weight heparin.
Gramse CA; Hingorani A; Ascher E
J Vasc Nurs; 2001 Jun; 19(2):42-9; quiz 50-1. PubMed ID: 11395717
[TBL] [Abstract][Full Text] [Related]
9. Preventing DVT following total knee replacement: a review of recent clinical trials.
Fitzgerald RH
Orthopedics; 1995 Jul; 18 Suppl():10-1. PubMed ID: 7479418
[TBL] [Abstract][Full Text] [Related]
10. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
11. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G
N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
13. Enoxaparin in the prevention of deep venous thrombosis.
Ament PW; Bertolino JG
Am Fam Physician; 1994 Dec; 50(8):1763-8. PubMed ID: 7977005
[TBL] [Abstract][Full Text] [Related]
14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
15. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
16. [Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
Ganzer D; Gutezeit A; Mayer G
Z Orthop Ihre Grenzgeb; 1999; 137(5):457-61. PubMed ID: 10549126
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
[TBL] [Abstract][Full Text] [Related]
18. Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin.
Lassen MR; Borris LC
Orthopedics; 1997 Feb; 20 Suppl():14-7. PubMed ID: 9048402
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
O'Brien BJ; Anderson DR; Goeree R
CMAJ; 1994 Apr; 150(7):1083-90. PubMed ID: 8137188
[TBL] [Abstract][Full Text] [Related]
20. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
